ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 (2020)
- Authors:
- USP affiliated authors: PERON, JEAN PIERRE SCHATZMANN - ICB ; NAKAYA, HELDER TAKASHI IMOTO - FCF ; OLIVEIRA, ANTONIO EDSON ROCHA - FCF ; SINGH, YOUVIKA - FCF ; GONÇALVES, ANDRÉ NICOLAU AQUIME - FCF
- Unidades: ICB; FCF
- DOI: 10.1093/infdis/jiaa332
- Subjects: ANGIOTENSINAS; COVID-19; COMORBIDADE; GENES; IMUNOLOGIA; INFECÇÕES RESPIRATÓRIAS; PNEUMOPATIAS; DOENÇAS CARDIOVASCULARES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Infectious Diseases
- ISSN: 1537-6613
- Volume/Número/Paginação/Ano: v. 222, p. 556-563, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PINTO, Bruna G. G et al. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. Journal of Infectious Diseases, v. 222, p. 556-563, 2020Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiaa332. Acesso em: 11 fev. 2026. -
APA
Pinto, B. G. G., Oliveira, A. E. R., Singh, Y., Gonçalves, A. N. A., Ogava, R. L. T., Creighton, R., et al. (2020). ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. Journal of Infectious Diseases, 222, 556-563. doi:10.1093/infdis/jiaa332 -
NLM
Pinto BGG, Oliveira AER, Singh Y, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HTI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 [Internet]. Journal of Infectious Diseases. 2020 ; 222 556-563.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1093/infdis/jiaa332 -
Vancouver
Pinto BGG, Oliveira AER, Singh Y, Gonçalves ANA, Ogava RLT, Creighton R, Peron JPS, Nakaya HTI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19 [Internet]. Journal of Infectious Diseases. 2020 ; 222 556-563.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1093/infdis/jiaa332 - An experimental DUAL model of advanced liver damage
- COVID-19 pandemic and dysbiosis: can the ivermectin hysteria lead to an increase of autoimmune neuroinflammatory diseases?
- Susceptibility of the elderly to sars-cov-2 infection: ace-2 overexpression, shedding, and antibody-dependent enhancement (ade)
- Immature neutrophil signature associated with the sexual dimorphism of systemic juvenile idiopathic arthritis
- Neuroinflammation at single cell level: what is new?
- Acid pH increases SARS-CoV-2 infection and the risk of death by COVID-19
- Endostatin gene therapy inhibits intratumoral macrophage M2 polarization
- Zika virus-associated brain damage: animal models and open issues
- O fenômeno da tolerância oral e a regulação de células patogênicas Th17 no modelo de encefalomielite experimental auto-imune
- The diterpene from Sphagneticola trilobata (L.) Pruski, kaurenoic acid, reduces lipopolysaccharide-induced peritonitis and pain in mice
Informações sobre o DOI: 10.1093/infdis/jiaa332 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
